These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 7700211)

  • 41. Ketoconazole-induced reduction in serum 1,25-dihydroxyvitamin D.
    Glass AR; Eil C
    J Clin Endocrinol Metab; 1986 Sep; 63(3):766-9. PubMed ID: 3755445
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of a two-month treatment with low oral doses of cyclosporin on renal function.
    Balletta M; Libetta C; Fuiano G; Delfino M; Brunetti B; Ungaro B; Conte G
    Nephrol Dial Transplant; 1991; 6(5):324-9. PubMed ID: 1870748
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Relationship between Serum 25-Hydroxyvitamin D, Parathyroid Hormone and the Glomerular Filtration Rate in Korean Adults: The Korea National Health and Nutrition Examination Survey between 2009 and 2011.
    Han SW; Kim SJ; Lee DJ; Kim KM; Joo NS
    Korean J Fam Med; 2014 Mar; 35(2):98-106. PubMed ID: 24724005
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Psoriasis: immunopathology and long-term treatment with cyclosporin.
    Fry L
    J Autoimmun; 1992 Apr; 5 Suppl A():277-83. PubMed ID: 1503622
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Renal insufficiency induced by parathyroid hormone: influence of the calcium antagonist Gö 6070.
    Strohmaier WL; Seeger D; Osswald H; Bichler KH
    Eur Urol; 1992; 21(4):323-7. PubMed ID: 1459155
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Drug-vitamin D interactions: a systematic review of the literature.
    Robien K; Oppeneer SJ; Kelly JA; Hamilton-Reeves JM
    Nutr Clin Pract; 2013 Apr; 28(2):194-208. PubMed ID: 23307906
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum ionized calcium, as well as phosphorus and parathyroid hormone, is associated with the plasma 1,25-dihydroxyvitamin D3 concentration in normal postmenopausal women.
    Dawson-Hughes B; Harris S; Dallal GE
    J Bone Miner Res; 1991 May; 6(5):461-8. PubMed ID: 2068951
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Renal effects of maintenance low-dose cyclosporin A treatment in psoriasis.
    Svarstad E; Helland S; Morken T; Bostad L; Myking A; Iversen BM; Ofstad J
    Nephrol Dial Transplant; 1994; 9(10):1462-7. PubMed ID: 7816261
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
    Mortensen BM; Gordeladze JO; Lyngdal PT; Aarseth HP; Gautvik KM
    Miner Electrolyte Metab; 1993; 19(2):78-85. PubMed ID: 8377728
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Angiotensin II as a risk factor for cyclosporin nephrotoxicity in patients with psoriasis.
    Edwards BD; Chalmers RJ; O'Driscoll JB; Mitchell DM; Smith RJ; Lawson RS; Testa HJ; Ballardie FW
    Clin Nephrol; 1994 Jun; 41(6):350-6. PubMed ID: 8076438
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interrelationship between serum concentrations of 1,25-dihydroxyvitamin D, parathyroid hormone and renal haemodynamics after low dose cyclosporin.
    Edwards BD; Davies M; Mawer EB; Chalmers RJ; Testa HJ; Ballardie FW
    Miner Electrolyte Metab; 1994; 20(5):250-4. PubMed ID: 7700211
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.